Company Search:
Advanced Search
Sponsored Links
Bioinvent International AB Company Snapshot
Bioinvent International AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioinvent International AB with three other companies in this sector in Sweden: Intervacc AB (2018 sales of 35.60 million Swedish Kronor [US$3.83 million] ), PledPharma AB (publ) (28.21 million Swedish Kronor [US$3.03 million] ), and Genovis AB (34.57 million Swedish Kronor [US$3.71 million] ).

Sales Analysis. Bioinvent International AB reported sales of SEK 38.55 million (US$4.14 million) for the year ending December of 2018. This represents a decrease of 14.4% versus 2017, when the company's sales were SEK 45.01 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bioinvent International AB
  Stock Performance Chart for Bioinvent International AB
  Stock Data: Recent Stock Performance:
  Current Price (4/18/2019): 1.45
(Figures in Swedish Kronor)
1 Week -8.8%   13 Weeks -9.3%  
4 Weeks -36.7%   52 Weeks -22.6%  
Bioinvent International AB Key Data:
  Ticker: BINV Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 38,548,000
(Year Ending Jan 2019).
Employees: 62
  Currency: Swedish Kronor Market Cap: 510,740,559
  Fiscal Yr Ends: December Shares Outstanding: 351,749,696
  Share Type: Ordinary Closely Held Shares: 150,730,557
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.